EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62019TN0678
Case T-678/19: Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)
Case T-678/19: Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)
Case T-678/19: Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)
OJ C 399, 25.11.2019, p. 99–99
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
25.11.2019 |
EN |
Official Journal of the European Union |
C 399/99 |
Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)
(Case T-678/19)
(2019/C 399/117)
Language of the case: English
Parties
Applicant: Health Product Group sp. z o.o. (Warsaw, Poland) (represented by: M. Kondrat, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Bioline Pharmaceutical AG (Baar, Switzerland)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: International registration designating the European Union in respect of the word mark Enterosgel – International registration designating the European Union No 896 788
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 8 August 2019 in Case R 482/2018-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision and cancel the trade mark; |
|
— |
award the costs in applicant’s favour. |
Plea in law
|
— |
Infringement of Article 59(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |